abstract:
The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status
Highlights
- •Ovarian tumor development through hormonal pathways may differ from breast cancer.
- •Postmenopausal women were more likely to develop PR(–) ovarian tumors.
- •Women with a tubal ligation tended to develop ERα(–) ovarian tumors.
Objective
We
assessed the association between reproductive and hormonal factors and
ovarian cancer incidence characterized by estrogen receptor-α (ERα) and
progesterone receptor (PR) status.
Conclusions
Postmenopausal women
have an increased risk of developing PR(–) ovarian tumors compared to
premenopausal women. The associations observed for ovarian cancer differ
from those seen for breast cancer suggesting that the biology for tumor
development through ERα and PR pathways may differ.
Methods
Tissue
microarrays were used to assess ERα and PR expression among 197 Nurses'
Health Study (NHS), 42 NHSII and 76 New England Case-Control Study
(NECC) ovarian cancer cases. NHS/NHSII cases were matched to up to 4
controls (n = 954) on diagnosis date and birth year. NECC controls
(n = 725) were frequency matched on age. Cases were considered receptor
positive if ≥
1%
of tumor cells stained positive. Associations by ERα and PR status were
assessed using polytomous logistic regression. p-Value for heterogeneity
was calculated using a likelihood ratio test.
Results
45% of ovarian tumors were PR
(+), 78% were ERα
(+) and 45% were ERα
(+)/PR
(+),
while 22% were ERα(–)/PR(–). Postmenopausal status was associated with
an increased risk of PR(–) tumors (OR: 2.07; 95%CI: 1.15–3.75;
p-heterogeneity = 0.01) and age at natural menopause was inversely
associated with PR(–) tumors (OR, per 5 years: 0.77; 95%CI: 0.61–0.96;
p-het = 0.01). Increasing duration of postmenopause was differentially
associated by PR status (p-het = 0.0009). Number of children and tubal
ligation were more strongly associated with ERα(–) versus ERα
(+)
tumors (p-het = 0.002 and 0.05, respectively). No differential
associations were observed for oral contraceptive or hormone therapy
use.
Conclusions
Postmenopausal women
have an increased risk of developing PR(–) ovarian tumors compared to
premenopausal women. The associations observed for ovarian cancer differ
from those seen for breast cancer suggesting that the biology for tumor
development through ERα and PR pathways may differ.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.